Business Description
Regenerative Medical Technology Group Inc
NAICS : 541714
SIC : 8731
ISIN : US59071L1035
Total Employee Number:
1Description
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -7.11 | |||||
Debt-to-Equity | -0.58 | |||||
Debt-to-EBITDA | 18.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -28.26 | |||||
Beneish M-Score | -9.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.9 | |||||
3-Year EBITDA Growth Rate | 56.1 | |||||
3-Year EPS without NRI Growth Rate | -12.7 | |||||
3-Year FCF Growth Rate | 0.9 | |||||
3-Year Book Growth Rate | -40 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.64 | |||||
9-Day RSI | 57.01 | |||||
14-Day RSI | 56.64 | |||||
3-1 Month Momentum % | 32.51 | |||||
6-1 Month Momentum % | -26.23 | |||||
12-1 Month Momentum % | -17.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.03 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 19.75 | |||||
Days Sales Outstanding | 2.82 | |||||
Days Payable | 44.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | 6.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.98 | |||||
Operating Margin % | -12.11 | |||||
Net Margin % | -124.36 | |||||
EBITDA Margin % | 17.91 | |||||
FCF Margin % | -15.32 | |||||
OCF Margin % | -10.38 | |||||
ROA % | -176.3 | |||||
ROIC % | -4.19 | |||||
3-Year ROIIC % | 3.28 | |||||
ROC (Joel Greenblatt) % | 69.28 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.09 | |||||
EV-to-EBIT | 24.65 | |||||
EV-to-EBITDA | 17.61 | |||||
EV-to-Revenue | 3.15 | |||||
EV-to-FCF | -20.59 | |||||
Price-to-GF-Value | 0.75 | |||||
Earnings Yield (Greenblatt) % | 4.06 | |||||
FCF Yield % | -164.48 |
Regenerative Medical Technology Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Regenerative Medical Technology Group Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.001:1 Stock Split | 2018-09-26 | 0.10 (+0.00%) | ||
| 0.001667:1 Stock Split | 2014-11-12 | 59.99 (+0.00%) | ||
| 0.005:1 Stock Split | 2007-08-21 | 120,481.93 (-50.00%) |
Show
Entries
Guru Commentaries on OTCPK:RMTG
No articles.
Press Release
Articles on Regenerative Medical Technology Group Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers